Valuation: Becton, Dickinson and Company

Market Cap 43.56B 38.08B 34.99B 32.62B 61.87B 4,147B 62.81B 420B 163B 2,039B 163B 160B 7,025B P/E 2026 *
39.4x
P/E 2027 * 30.4x
Enterprise Value 59.51B 52.03B 47.81B 44.57B 84.53B 5,666B 85.81B 574B 223B 2,785B 223B 219B 9,598B EV / Sales 2026 *
3.1x
EV / Sales 2027 * 2.92x
Free-Float
74.04%
Yield 2026 *
2.44%
Yield 2027 * 2.48%
1 day+3.39%
1 week+1.39%
Current month+4.46%
1 month+8.56%
3 months+2.31%
6 months-18.91%
Current year-18.54%
1 week 149.69
Extreme 149.69
158.72
1 month 140.11
Extreme 140.11
158.72
Current year 140.11
Extreme 140.11
213.08
1 year 140.11
Extreme 140.11
213.08
3 years 140.11
Extreme 140.11
287.32
5 years 140.11
Extreme 140.11
287.32
10 years 140.11
Extreme 140.11
287.32
Manager TitleAgeSince
Chief Executive Officer 53 28/01/2020
Director of Finance/CFO 44 05/12/2025
Compliance Officer - 01/02/2023
Director TitleAgeSince
Director/Board Member 75 24/09/2002
Director/Board Member 71 26/07/2010
Chairman 53 28/04/2021
Date Insider Type Main position Quantity % Market Cap.
26/06Sell

Executive/Senior Manager

-75 0.0000%
24/06Sell

Executive/Senior Manager

-1,100 0.0004%
22/06Other

EVP and Chief People Officer

39,984 0.0145%
Change 5-day change 1-year change 3-year change Capi.($)
+3.39%+1.39%-10.26%-39.65% 43.56B
+3.49%+1.36%-29.04%-11.02% 166B
+5.04%+2.73%-5.88%-4.53% 106B
+2.80%+3.63%+0.09%+55.31% 57.69B
+1.33%+1.39%+53.16%+49.84% 53.78B
+3.50%+11.11% - - 36.52B
+3.47%+1.58%-14.08%-43.91% 27.49B
+0.20%+4.24%+64.56%-3.33% 25.84B
+2.78%+1.17%-8.15%-0.43% 21.27B
+1.96%+2.08%-8.43%-1.27% 20.65B
Average +2.80%+4.42%+4.66%+0.11% 55.95B
Weighted average by Cap. +3.26%+3.74%-4.02%+0.96%

Financials

2026 *2027 *
Net sales 19.21B 16.79B 15.43B 14.38B 27.28B 1,829B 27.69B 185B 72.01B 899B 72.09B 70.54B 3,097B 19.71B 17.23B 15.84B 14.76B 28B 1,877B 28.42B 190B 73.9B 923B 73.99B 72.4B 3,179B
Net income 1.12B 983M 904M 842M 1.6B 107B 1.62B 10.85B 4.22B 52.64B 4.22B 4.13B 181B 1.45B 1.27B 1.16B 1.09B 2.06B 138B 2.09B 13.98B 5.43B 67.83B 5.44B 5.32B 234B
Net Debt 15.95B 13.95B 12.82B 11.95B 22.66B 1,519B 23.01B 154B 59.82B 747B 59.89B 58.6B 2,573B 14.07B 12.3B 11.31B 10.54B 19.99B 1,340B 20.29B 136B 52.76B 659B 52.82B 51.69B 2,270B
Logo Becton, Dickinson and Company
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical management systems (52.4%): medication delivery systems, pharmaceutical systems, advanced patient monitoring systems, etc.; - interventional medical equipment (23.9%): surgical instruments, urological care products, etc.; - diagnostic materials and clinical research and development tools (23.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, tools for studying genes and culturing cells, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (58.6%), Europe/Middle East/Africa (21.6%), Asia (14.2%) and other (5.6%).
Employees
72,000
Date Price Change Volume
02/07/26 USD 158.08 +3.39% 2,040,521
01/07/26 USD 152.90 +1.04% 2,131,647
30/06/26 USD 151.33 -2.49% 2,109,075
29/06/26 USD 155.19 -0.47% 2,396,596
26/06/26 USD 155.92 +3.00% 12,180,748
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
158.08USD
Average target price
177.75USD
Spread / Average Target
+12.44%

Quarterly revenue - Rate of surprise